Search results
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 21 hours agoAt the end of the trading day, the stock’s price was $154.84, reflecting an intraday gain of 6.54% or $9.5. The 52-week high for the MRNA share is $170.47 ...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 14 hours agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 10 hours agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 8 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
5 Stocks Propelling S&P 500 to 25th Record High
Zacks via Yahoo Finance· 14 hours agoThe S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO,...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoSales are expected to accelerate in a big way in the third quarter, with a projected $1.5 billion,...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 13 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 15 hours agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days agoBiotech stocks generally rise after a product they spent years developing earns marketing approval,...